Your browser doesn't support javascript.
loading
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
Wu, Xiaoning; Scott, Helen; Carlsson, Sigrid V; Sjoberg, Daniel D; Cerundolo, Lucia; Lilja, Hans; Prevo, Remko; Rieunier, Guillaume; Macaulay, Valentine; Higgins, Geoffrey S; Verrill, Clare L; Lamb, Alastair D; Cunliffe, Vincent T; Bountra, Chas; Hamdy, Freddie C; Bryant, Richard J.
Afiliação
  • Wu X; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
  • Scott H; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
  • Carlsson SV; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Sjoberg DD; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cerundolo L; Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lilja H; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • Prevo R; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rieunier G; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Macaulay V; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Higgins GS; Department of Laboratory Medicine, Surgery (Urology), and Medicine (GU-Oncology), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Verrill CL; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Lamb AD; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
  • Cunliffe VT; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Bountra C; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Hamdy FC; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
  • Bryant RJ; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Prostate ; 79(10): 1079-1089, 2019 07.
Article em En | MEDLINE | ID: mdl-31104332
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Proteína Potenciadora do Homólogo 2 de Zeste Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Proteína Potenciadora do Homólogo 2 de Zeste Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido